Proarrhythmia Induced by Propafenone: What is the Mechanism?
Francisco Femenía, Jorge Palazzolo, Mauricio Arce, Martín Arrieta
Abstract
Francisco Femenía, Jorge Palazzolo, Mauricio Arce, Martín Arrieta
Abstract
Propafenone, a Class IC antiarrhythmic drug, is an orally active sodium channel-blocking agent. It is effective in supraventricular tachyarrhythmias and is particularly useful in converting atrial fibrillation to sinus rhythm. In therapeutic doses, it may cause non-cardiac and cardiac toxicity, including proarrhythmia.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Propafenone, a Class IC antiarrhythmic drug, is an orally active sodium channel-blocking agent. It is effective in supraventricular tachyarrhythmias and is particularly useful in converting atrial fibrillation to sinus rhythm. In therapeutic doses, it may cause non-cardiac and cardiac toxicity, including proarrhythmia.
Key concepts: Proarrhythmia, Propafenone, Medicine, Supraventricular arrhythmia, Sinus rhythm, Torsades de pointes, Cardiology, Atrial fibrillation